Cargando…

Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum

The cholinergic class of anthelmintic drugs is used for the control of parasitic nematodes. One of this class of drugs, tribendimidine (a symmetrical diamidine derivative, of amidantel), was developed in China for use in humans in the mid-1980s. It has a broader-spectrum anthelmintic action against...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson, Alan P., Puttachary, Sreekanth, Buxton, Samuel K., Martin, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334517/
https://www.ncbi.nlm.nih.gov/pubmed/25679515
http://dx.doi.org/10.1371/journal.pntd.0003495
_version_ 1782358198960783360
author Robertson, Alan P.
Puttachary, Sreekanth
Buxton, Samuel K.
Martin, Richard J.
author_facet Robertson, Alan P.
Puttachary, Sreekanth
Buxton, Samuel K.
Martin, Richard J.
author_sort Robertson, Alan P.
collection PubMed
description The cholinergic class of anthelmintic drugs is used for the control of parasitic nematodes. One of this class of drugs, tribendimidine (a symmetrical diamidine derivative, of amidantel), was developed in China for use in humans in the mid-1980s. It has a broader-spectrum anthelmintic action against soil-transmitted helminthiasis than other cholinergic anthelmintics, and is effective against hookworm, pinworms, roundworms, and Strongyloides and flatworm of humans. Although molecular studies on C. elegans suggest that tribendimidine is a cholinergic agonist that is selective for the same nematode muscle nAChR as levamisole, no direct electrophysiological observations in nematode parasites have been made to test this hypothesis. Also the hypothesis that levamisole and tribendimine act on the same receptor, does not explain why tribendimidine is effective against some nematode parasites when levamisole is not. Here we examine the effects of tribendimidine on the electrophysiology and contraction of Ascaris suum body muscle and show that tribendimidine produces depolarization antagonized by the nicotinic antagonist mecamylamine, and that tribendimidine is an agonist of muscle nAChRs of parasitic nematodes. Further pharmacological characterization of the nAChRs activated by tribendimidine in our Ascaris muscle contraction assay shows that tribendimidine is not selective for the same receptor subtypes as levamisole, and that tribendimidine is more selective for the B-subtype than the L-subtype of nAChR. In addition, larval migration inhibition assays with levamisole-resistant Oesophagostomum dentatum isolates show that tribendimidine is as active on a levamisole-resistant isolate as on a levamisole-sensitive isolate, suggesting that the selectivity for levamisole and tribendimidine is not the same. It is concluded that tribendimidine can activate a different population of nematode parasite nAChRs than levamisole, and is more like bephenium. The different nAChR subtype selectivity of tribendimidine may explain why the spectrum of action of tribendimidine is different to that of other cholinergic anthelmintics like levamisole.
format Online
Article
Text
id pubmed-4334517
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43345172015-02-24 Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum Robertson, Alan P. Puttachary, Sreekanth Buxton, Samuel K. Martin, Richard J. PLoS Negl Trop Dis Research Article The cholinergic class of anthelmintic drugs is used for the control of parasitic nematodes. One of this class of drugs, tribendimidine (a symmetrical diamidine derivative, of amidantel), was developed in China for use in humans in the mid-1980s. It has a broader-spectrum anthelmintic action against soil-transmitted helminthiasis than other cholinergic anthelmintics, and is effective against hookworm, pinworms, roundworms, and Strongyloides and flatworm of humans. Although molecular studies on C. elegans suggest that tribendimidine is a cholinergic agonist that is selective for the same nematode muscle nAChR as levamisole, no direct electrophysiological observations in nematode parasites have been made to test this hypothesis. Also the hypothesis that levamisole and tribendimine act on the same receptor, does not explain why tribendimidine is effective against some nematode parasites when levamisole is not. Here we examine the effects of tribendimidine on the electrophysiology and contraction of Ascaris suum body muscle and show that tribendimidine produces depolarization antagonized by the nicotinic antagonist mecamylamine, and that tribendimidine is an agonist of muscle nAChRs of parasitic nematodes. Further pharmacological characterization of the nAChRs activated by tribendimidine in our Ascaris muscle contraction assay shows that tribendimidine is not selective for the same receptor subtypes as levamisole, and that tribendimidine is more selective for the B-subtype than the L-subtype of nAChR. In addition, larval migration inhibition assays with levamisole-resistant Oesophagostomum dentatum isolates show that tribendimidine is as active on a levamisole-resistant isolate as on a levamisole-sensitive isolate, suggesting that the selectivity for levamisole and tribendimidine is not the same. It is concluded that tribendimidine can activate a different population of nematode parasite nAChRs than levamisole, and is more like bephenium. The different nAChR subtype selectivity of tribendimidine may explain why the spectrum of action of tribendimidine is different to that of other cholinergic anthelmintics like levamisole. Public Library of Science 2015-02-13 /pmc/articles/PMC4334517/ /pubmed/25679515 http://dx.doi.org/10.1371/journal.pntd.0003495 Text en © 2015 Robertson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Robertson, Alan P.
Puttachary, Sreekanth
Buxton, Samuel K.
Martin, Richard J.
Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title_full Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title_fullStr Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title_full_unstemmed Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title_short Tribendimidine: Mode of Action and nAChR Subtype Selectivity in Ascaris and Oesophagostomum
title_sort tribendimidine: mode of action and nachr subtype selectivity in ascaris and oesophagostomum
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334517/
https://www.ncbi.nlm.nih.gov/pubmed/25679515
http://dx.doi.org/10.1371/journal.pntd.0003495
work_keys_str_mv AT robertsonalanp tribendimidinemodeofactionandnachrsubtypeselectivityinascarisandoesophagostomum
AT puttacharysreekanth tribendimidinemodeofactionandnachrsubtypeselectivityinascarisandoesophagostomum
AT buxtonsamuelk tribendimidinemodeofactionandnachrsubtypeselectivityinascarisandoesophagostomum
AT martinrichardj tribendimidinemodeofactionandnachrsubtypeselectivityinascarisandoesophagostomum